Survival after Starting Renal Replacement Treatment in Patients with Autosomal Dominant Polycystic Kidney Disease: A Single-Centre 40-Year Study

被引:11
作者
Haynes, Richard [1 ]
Kheradmand, Farhad [2 ]
Winearls, Christopher G. [1 ]
机构
[1] Oxford Univ Hosp NHS Trust, Oxford Kidney Unit, Churchill Hosp, Oxford OX3 7LJ, England
[2] Oxford Univ Hosp NHS Trust, Dept Urol, Churchill Hosp, Oxford OX3 7LJ, England
来源
NEPHRON CLINICAL PRACTICE | 2012年 / 120卷 / 01期
关键词
Adult polycystic kidney disease; Dialysis; Survival; Transplant; MORTALITY; METAANALYSIS; DIALYSIS;
D O I
10.1159/000334429
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Adult polycystic kidney disease (ADPKD) has a predictable natural history and the relative lack of comorbidity allows a relatively unconfounded assessment of survival. We examined whether survival on renal replacement treatment (RRT) has improved over the last four decades compared to that in the general population. Methods: We conducted a retrospective cohort study of all patients with ADPKD who received RRT between 1971 and 2000 at the Oxford Kidney Unit. The main exposure was period of start of treatment (1971-1985 vs. 1986-2000) and the key outcome was overall survival. Standard Cox regression techniques were used to assess the association between these baseline variables and survival. Results: Age at start of RRT (HR per 1 year 1.08; 95% CI 1.06-1.10) and presence of a functioning transplant (HR 0.22; 95% CI 0.16-0.31) were associated with improved survival in unadjusted analyses. After adjustment for age the period of treatment also became a significant predictor of overall survival (HR 0.67; 95% CI 0.47-0.97). Conclusions: Survival on RRT appears to have improved and exceeds that observed in the general population, such that RRT now provides almost two-thirds of the life expectancy of the general population, compared to about half in earlier decades. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:C42 / C47
页数:6
相关论文
共 17 条
[1]  
[Anonymous], 2006, USRDS 2006 ANN DAT R
[2]   Evolving Trends in Clinical Presentation of and Renal Replacement Therapy for Chronic Kidney Disease [J].
Ansell, David ;
Tomson, Charles R. V. .
NEPHRON CLINICAL PRACTICE, 2009, 111 (04) :C265-C267
[3]   Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease [J].
Ecder, T ;
Chapman, AB ;
Brosnahan, GM ;
Edelstein, CL ;
Johnson, AM ;
Schrier, RW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (03) :427-432
[4]  
Farrington Ken, 2009, Nephron Clin Pract, V111 Suppl 1, pc13, DOI 10.1159/000209992
[5]   Autosomal dominant polycystic kidney disease [J].
Grantham, Jared J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (14) :1477-1485
[6]   Comparison of phenotypes of polycystic kidney disease types 1 and 2 [J].
Hateboer, N ;
Dijk, MAV ;
Bogdanova, N ;
Coto, E ;
Saggar-Malik, AK ;
San Millan, JL ;
Torra, R ;
Breuning, M ;
Ravine, D .
LANCET, 1999, 353 (9147) :103-107
[7]   The Achilles Heel of Mortality Risk by Dialysis Modality is Selection Bias [J].
Jaar, Bernard G. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (08) :1398-1400
[8]   The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease [J].
Jafar, TH ;
Stark, PC ;
Schmid, CH ;
Strandgaard, S ;
Kamper, AL ;
Maschio, G ;
Becker, G ;
Perrone, RD ;
Levey, AS .
KIDNEY INTERNATIONAL, 2005, 67 (01) :265-271
[9]  
Kasiske BL, 2000, J AM SOC NEPHROL, V11, P1910, DOI 10.1681/ASN.V11101910
[10]   Improved Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease in Denmark [J].
Orskov, Bjarne ;
Sorensen, Vibeke Romming ;
Feldt-Rasmussen, Bo ;
Strandgaard, Svend .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (11) :2034-2039